Summary
Ali Rizvi works in the Lupus Clinical Trials Unit at NIAMS conducting vascular studies for the Natural History of Atherosclerosis protocol. His research on the risk factors for systemic lupus erythematosus involves analyzing patient data to determine the risk of fracture from extended prednisone use. The aim is to improve patient outcomes and gain a better understanding of the disease.
Ali's background in neuroscience and biotechnology and his patient care experiences are crucial to his goal of pursuing a medical degree.
Education
George Mason University
B.S. in Neuroscience (2018-2022)
Georgetown University
M.S. in Biotechnology (2022-2023)
Experience
Postbaccalaureate IRTA
National Institute of Health (NIAMS)
Machine Learning Technician
Amelia Technologies, LLC
